5Brayden DJ. Controlled release technologies for drug de- livery[J]. Drug Discov Today, 2003, 8(21):976-978.
6Mozafari MR, Johnson C, Hatziantoniou S, et al. Nanoli- posomes and their applications in food nanotechnology[J]. J Liposome Res, 2008, 18(4):309-327.
7Holzhausen M, Rossa Jflnior C, Marcantonio Jfinior E, et al. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats[J]. J Periodontol, 2002, 73(9): 1030-1036.
8Gomes PS, Femandes MH. Effect of therapeutic levels of doxycycline and minocycline in the proliferation and dif- ferentiation of human bone marrow osteoblastic cells[J]. Arch Oral Biol, 2007, 52(3):251-259.
9Pytlik M, Folwarczna J, Janiec W. Effects of doxycycline on mechanical properties of bones in rats with ovariectomy- induced osteopenia[J]. Calcif Tissue Int, 2004, 75(3):225- 230.
10Garlet GP, Martins W Jr, Fonseca BA, et al. Matrix me- talloproteinases, their physiological inhibitors and osteo- clast factors are differentially regulated by the cytokine profile in human periodontal disease[J]. J Clin Periodontol, 2004, 31(8):671-679.
